Publications by authors named "Edward Visse"

Claim this Profile
O
Outcome in adult patients with severe TBI, using a management protocol allowing a cerebral perfusion pressure ≤ 60 mmHg - a retrospective study over 10 years.
Linus Réen, Anna Radman, Edward Visse, David Cederberg, Niklas Marklund

Acta Neurochir (Wien)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Neurocritical Care Management of Patients with Severe Traumatic Brain Injury Following Changed Positions of the Zero-Reference Points for Intracranial and Arterial Pressure Measurement.
Linus Réen, Hannes Wikström, Edward Visse, David Cederberg, Peter Siesjö

Neurocrit Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial.
Erik Ehinger, Anna Darabi, Edward Visse, Charlotte Edvardsson, Gregor Tomasevic

Trials· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisecretory factor in severe traumatic brain injury (AFISTBI): protocol for an exploratory randomized placebo-controlled trial.
Linus Réen, David Cederberg, Niklas Marklund, Edward Visse, Peter Siesjö

Trials· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Morbidity and Mortality in Children with Severe Traumatic Brain Injury Treated According to the Lund Concept: A Population-Based Study.
Linus Réen, David Cederberg, Anna Radman, Niklas Marklund, Edward Visse

J Neurotrauma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes.
David Cederberg, Edward Visse, Niklas Marklund, Peter Siesjö

J Neuroimmunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma.
Erik Ehinger, Jan Kopecky, Anna Darabi, Edward Visse, Charlotte Edvardsson

BMC Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer.
Christopher Godina, Vineesh Indira Chandran, Magdalena Barbachowska, Helga Tryggvadottir, Björn Nodin, Edward Visse

Transl Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions.
Jan Kopecky, Julio Enríquez Pérez, Håkan Eriksson, Edward Visse, Peter Siesjö

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study.
Christopher Godina, Somayeh Khazaei, Helga Tryggvadottir, Edward Visse, Björn Nodin

Carcinogenesis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisecretory Factor May Reduce ICP in Severe TBI-A Case Series.
David Cederberg, Hans-Arne Hansson, Edward Visse, Peter Siesjö

Front Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
Julio Enríquez Pérez, Jan Kopecky, Edward Visse, Anna Darabi, Peter Siesjö

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model.
Julio Enríquez Pérez, Sara Fritzell, Jan Kopecky, Edward Visse, Anna Darabi

Sci Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.
Emma Sandén, Cecilia Dyberg, Cecilia Krona, Gabriel Gallo-Oller, Thale Kristin Olsen, Edward Visse

Sci Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors.
Emma Sandén, Julio Enríquez Pérez, Edward Visse, Marcel Kool, Helena Carén

Pediatr Blood Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.
Emma Sandén, Sofia Eberstål, Edward Visse, Peter Siesjö, Anna Darabi

Sci Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
Emma Sandén, Cecilia Dyberg, Cecilia Krona, Edward Visse, Helena Carén

J Neurooncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory.
Sofia Eberstål, Sara Fritzell, Emma Sandén, Edward Visse, Anna Darabi

J Neuroimmunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
Sofia Eberstål, Emma Sandén, Sara Fritzell, Anna Darabi, Edward Visse

Int J Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
Sara Fritzell, Emma Sandén, Sofia Eberstål, Edward Visse, Anna Darabi

Cancer Immunol Immunother· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
Sara Fritzell, Sofia Eberstål, Emma Sandén, Edward Visse, Anna Darabi

J Neuroimmunol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
Sofia Eberstål, Wiaam Badn, Sara Fritzell, Magnus Esbjörnsson, Anna Darabi, Edward Visse

Cancer Immunol Immunother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adult human brain harbors multipotent perivascular mesenchymal stem cells.
Gesine Paul, Ilknur Özen, Nicolaj S Christophersen, Thomas Reinbothe, Johan Bengzon, Edward Visse

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
Shorena Janelidze, Daniel Bexell, Wiaam Badn, Anna Darabi, Karin-Enell Smith, Edward Visse

J Immunother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
Karin Enell Smith, Sara Fritzell, Wiaam Badn, Sofia Eberstål, Shorena Janelidze, Edward Visse

Int J Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis